TAK Price Prediction Next Week
Technical Analysis: Based on recent price action, TAK has formed a bearish pattern with declining highs and lows. The stock is currently trading below both its 20-day moving average ($13.12) and 60-day moving average ($13.44), indicating a bearish trend. The RSI at 42.95 suggests neutral momentum but with a slight bearish bias.
News Impact Analysis: Recent key developments affecting TAK:
Positive: Health Canada authorized FRUZAQLA for treating metastatic colorectal cancer patients, which could provide new revenue opportunities.
Negative: FDA's ban on Red No. 3 affecting TAK's Vyvanse medication, though impact will be limited as it's effective from January 2027.
Concerning: Vyvanse revenues are already down 17.90% due to loss of exclusivity in the United States.
Price Prediction for Next Week: Based on technical and fundamental factors:
- Support levels: $12.85 (Fibonacci S1)
- Resistance levels: $13.15 (Fibonacci R1)
Expected price range: $12.85-$13.15
Target price: $12.90
Trading Recommendation: SELL
Rationale:
- Technical indicators show bearish momentum with price below key moving averages
- Loss of exclusivity for key drug Vyvanse impacting revenues
- While new drug approvals are positive, they are unlikely to offset near-term revenue losses
- Fibonacci levels suggest limited upside potential with stronger support at lower levels
The stock is likely to test support levels next week due to continued selling pressure and broader market uncertainty around pharmaceutical sector patent cliffs.
TAK Similar Chart Price Prediction
The price of TAK is predicted to go up 5.95%, based on the high correlation periods with FELE. The similarity of these two price pattern on the periods is 93.59%.
TAK
FELE
Up: 5.95%Similarity: 93.59%